ANHUI SHENGZHIKAI BIOTECHNOLOGYCO.,LTD.
Phone:+86 19155187336(whatsapp)
Email:shengzhikai3@shengzhikai.com
Address: 903, block B, Fortune Plaza, Luyang District, Hefei City, Anhui Province
----------------------------------------------------------------------------------------------------------------------------------------------
Specification of Analysis
Items | Standards | Results |
Appearance | White or off-white crystalline powder | Complies |
Identification | By IR | Complies |
By HPLC | Complies |
pH | 2.5~3.5 | 2.8 |
Loss on Drying | ≤ 1.00% | 0.30% |
Heavy Metals | ≤ 10ppm | Complies |
Residue on Ignition | ≤ 0.10% | 0.04% |
Relative Substance | Any single impurity: ≤0.50% | 0.15% |
Total Impurities: ≤1.00% | 0.48% |
Purity(by HPLC) | ≥ 99.0% | 99.52% |
Assay (on the anhydrous basis) | 99.0%~101.5% | 99.58% |
Reference Standard | In-house Standard |
Conclusion | The product complied to In-house standard. |
Storage | Preserve in tight,light-resistant containers in a cool place |
What is prasugrel?
Prasugrel (trade name Effient in the US and India, and Efient in the EU) is a pharmaceutical drug that acts as a platelet inhibitor and is used to prevent thrombosis (blood clotting). It was developed by Daiichi Sankyo Co. and produced by Ube and currently marketed in the United States in cooperation with Eli Lilly and Company.
Prasugrel was approved for use in Europe in February 2009, and in the US in July 2009, for the reduction of thrombotic cardiovascular events (including stent thrombosis) in people with acute coronary syndrome (ACS) who are to be managed with percutaneous coronary intervention (PCI).
Fuction and Application of prasugrel
Prasugrel is a new oral effective thienopyridine drug. Like clopidogrel, prasugrel is an inactive prodrug that is metabolically converted to an active metabolite by the cytochrome P450 enzyme system to irreversibly inhibit P2Y12 adenosine diphosphate receptors on platelets. Prasugrel is superior to clopidogrel, which explains why its pharmacokinetic properties are improved: prasugrel has a higher conversion of pro-drugs to active metabolites and higher bioavailability, so it is more effective. Rapidly and can reduce the difference in efficacy between individuals, to a greater extent reduce the incidence of major ischemic cardiovascular events.
HOT SELLING
CAS Common Name
28578-16-7 PMK ethyl glycidate
20320-59-6 Diethyl(phenylacetyl)malonate
288573-56-8 tert-butyl 4-(4-fluoroanilino)piperidine-1-carboxylate
49851-31-2 2-Bromo-1-phenyl-1-pentanone
62-44-2 Phenacetin
236117-38-7 2-iodo-1-p-tolylpropan-1-one
79099-07-3 N-(tert-Butoxycarbonyl)-4-piperidone
102-97-6 Benzylisopropylamine
40064-34-4 4,4-Piperidinediol hydrochloride
94-24-6 Tetracaine
1451-82-7 2-Bromo-4'-methylpropiophenone
2114-39-8 2-bromo-1-phenylpropane
23076-35-9 Xylazine hydrochloride
5061-21-2 3-Bromdihydrofuran-2(3H)-on
59-67-6 Nicotinic acid
50-56-6 Oxytocin acetate salt
132112-35-7 Ropivacaine hydrochloride
Company Information
Anhui shengzhikai Biotechnology Co., Ltd. is a high-tech enterprise dedicated to the fields of fine chemical products. The scope of products covers pharmaceutical intermediates, plant extracts, chemical reagent, animal pharmaceutical, agrochemical intermediates, antibiotic and so on.
Our customers are all over the world, mainly selling in the United States, Canada, Australia, the United Kingdom, the Netherlands, Germany, France and other EU countries, Southeast Asia, South America, and Oceania. We also have many customers.
Our business is based on honesty and mutual trust. Sincerely look forward to establishing long-term mutually beneficial business relationships with customers around the world.
Packing & Shipping